OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $161,791 | +304.6% | 17,917 | +9.8% | 0.02% | +240.0% |
| Q4 2022 | $39,989 | -25.9% | 16,322 | -16.9% | 0.01% | +25.0% |
| Q3 2022 | $54,000 | -67.7% | 19,652 | -52.0% | 0.00% | -71.4% |
| Q2 2022 | $167,000 | -34.5% | 40,946 | -31.6% | 0.01% | -33.3% |
| Q1 2022 | $255,000 | -64.7% | 59,824 | -22.5% | 0.02% | -67.2% |
| Q4 2021 | $723,000 | – | 77,203 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |